Watch this video to learn more about:
- The impact of Alzheimer’s on society
- How the current system for testing Alzheimer’s drugs is failing
- How stem cells are helping researchers overcome traditional limitations to Alzheimer’s research
Alzheimer’s is a devastating neurological disease affecting 44 million people worldwide. 1 in 3 seniors will die with it or a related dementia. The cost of treating Alzheimer’s is expected to quadruple, to more than $1 trillion in the U.S. by 2030, if no breakthrough treatments reach the market.
However: scientists, caregivers, and advocates are optimistic. This panel discussion features NYSCF’s Drs. Elizabeth Schwarzbach and Scott Noggle, Mount Sinai’s Dr. Sam Gandy, and patient advocates Alex Lerner and Dan Gasby.